Rhythm Pharmaceuticals (RYTM) News Today → Bible Shocker: Have You Seen Elon Musk’s Miracle? (From InvestorPlace) (Ad) Free RYTM Stock Alerts $37.96 -1.21 (-3.09%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15, 2024 | finance.yahoo.comRhythm Pharmaceuticals, Inc. (RYTM)May 14, 2024 | americanbankingnews.comRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Insider Joseph Shulman Sells 3,984 Shares of StockMay 14, 2024 | insidertrades.comJoseph Shulman Sells 3,984 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) StockMay 14, 2024 | marketbeat.comVictory Capital Management Inc. Buys 162,247 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)Victory Capital Management Inc. boosted its stake in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 809.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 182,297 shares of the comMay 13, 2024 | marketbeat.comInsider Selling: Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Insider Sells 3,984 Shares of StockRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Get Free Report) insider Joseph Shulman sold 3,984 shares of the stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $38.47, for a total value of $153,264.48. Following the completion of the sale, the insider now directly owns 30 shares of the company's stock, valued at approximately $1,154.10. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.May 12, 2024 | americanbankingnews.comBank of America Lowers Rhythm Pharmaceuticals (NASDAQ:RYTM) to NeutralMay 11, 2024 | americanbankingnews.comRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives $54.33 Average Price Target from AnalystsMay 9, 2024 | msn.comMario Lemieux Foundation presents AHN with $5 million gift to establish Mario Lemieux Center for Heart Rhythm CareMay 9, 2024 | msn.comLeon Talks Transformative Portrayal of Blues Legend Eddie Taylor in ‘The Rhythm and the Blues’ | EUR ExclusiveMay 9, 2024 | marketbeat.comNational Bank of Canada FI Boosts Stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)National Bank of Canada FI lifted its holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 82.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 239,000 shares of the compaMay 9, 2024 | msn.comB of A Securities Downgrades Rhythm Pharmaceuticals (RYTM)May 9, 2024 | americanbankingnews.comNeedham & Company LLC Lowers Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target to $46.00May 8, 2024 | msn.comSpin Rhythm XD - Official VR & PlayStation Launch TrailerMay 8, 2024 | markets.businessinsider.comSteady Performance and Promising European Growth Justify Buy Rating for Rhythm PharmaceuticalsMay 8, 2024 | markets.businessinsider.comMaintaining Buy Rating on Rhythm Pharmaceuticals: Positive Outlook Amidst Growth and Upcoming CatalystsMay 8, 2024 | finance.yahoo.comRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q1 2024 Earnings Call TranscriptMay 8, 2024 | marketbeat.comRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives Average Recommendation of "Moderate Buy" from BrokeragesRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six research firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the compaMay 8, 2024 | marketbeat.comRhythm Pharmaceuticals (NASDAQ:RYTM) PT Lowered to $79.00Canaccord Genuity Group reduced their target price on shares of Rhythm Pharmaceuticals from $80.00 to $79.00 and set a "buy" rating for the company in a report on Wednesday.May 8, 2024 | marketbeat.comRhythm Pharmaceuticals (NASDAQ:RYTM) Posts Earnings Results, Misses Expectations By $0.01 EPSRhythm Pharmaceuticals (NASDAQ:RYTM - Get Free Report) issued its earnings results on Tuesday. The company reported ($2.35) EPS for the quarter, missing the consensus estimate of ($2.34) by ($0.01). Rhythm Pharmaceuticals had a negative return on equity of 96.02% and a negative net margin of 238.50%. The firm had revenue of $26.00 million during the quarter, compared to analyst estimates of $26.90 million. During the same quarter in the previous year, the business posted ($0.92) EPS. Rhythm Pharmaceuticals's revenue was up 126.1% compared to the same quarter last year.May 8, 2024 | finance.yahoo.comRhythm Pharmaceuticals Inc (RYTM) Q1 2024 Earnings Call Transcript Highlights: A Detailed ...May 8, 2024 | marketbeat.comRhythm Pharmaceuticals (NASDAQ:RYTM) Lowered to "Neutral" at Bank of AmericaBank of America cut shares of Rhythm Pharmaceuticals from a "buy" rating to a "neutral" rating and dropped their price target for the stock from $49.00 to $42.00 in a research note on Wednesday.May 8, 2024 | finance.yahoo.comQ1 2024 Rhythm Pharmaceuticals Inc Earnings CallMay 7, 2024 | markets.businessinsider.comBuy Rating Affirmed: Rhythm Pharmaceuticals’ Growth and Clinical Advancements Fuel OptimismMay 7, 2024 | markets.businessinsider.comBuy Rating Affirmed for Rhythm Pharmaceuticals Amid Positive Prescription Growth and Pipeline PotentialMay 7, 2024 | msn.comRYTM Stock Earnings: Rhythm Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024May 7, 2024 | investorplace.comThe 3 Best Nasdaq Stocks to Buy in May 2024May 7, 2024 | marketbeat.comRhythm Pharmaceuticals (NASDAQ:RYTM) Given New $46.00 Price Target at Needham & Company LLCNeedham & Company LLC cut their price objective on Rhythm Pharmaceuticals from $50.00 to $46.00 and set a "buy" rating on the stock in a research note on Tuesday.May 7, 2024 | msn.comMarvelle Healthcare Revolutionizes Hydration with the Debut of Premium Natural Mineral Water Brand, RhythmMay 7, 2024 | msn.comRhythm Pharmaceuticals GAAP EPS of -$2.35 misses by $0.33, revenue of $25.97M misses by $0.93MMay 7, 2024 | finance.yahoo.comRhythm Pharmaceuticals Reports Q1 2024 Results: Revenue Growth Amidst ChallengesMay 7, 2024 | globenewswire.comRhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business UpdateMay 6, 2024 | finance.yahoo.comRhythm Pharmaceuticals Presents Data from Phase 3 Pediatrics Trial at Pediatric Endocrine Society Annual MeetingMay 3, 2024 | msn.comAnMed Rhythm on the River in Powdersville postponed: Here's what you need to knowMay 2, 2024 | msn.comCelebrate dance with ‘Rhythm and Joy': A Kathak choreography by Shovana NarayanMay 2, 2024 | msn.comRhythm and Roots Festival's founder, Chuck Wentworth, passes away at 72May 2, 2024 | finance.yahoo.comCardiac Monitoring & Cardiac Rhythm Management Devices Market Worth $26.4 billion | MarketsandMarkets™April 30, 2024 | marketbeat.comRhythm Pharmaceuticals (NASDAQ:RYTM) Trading 5.5% Higher Rhythm Pharmaceuticals (NASDAQ:RYTM) Trading Up 5.5%April 30, 2024 | marketbeat.comRhythm Pharmaceuticals (RYTM) Set to Announce Quarterly Earnings on TuesdayRhythm Pharmaceuticals (NASDAQ:RYTM) will be releasing earnings before the market opens on Tuesday, May 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=589001)April 30, 2024 | yahoo.com'Bigger than the music': Legendary producer of Rhythm & Roots Festival diesApril 29, 2024 | globenewswire.comRhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & EndocrinologyApril 26, 2024 | marketbeat.comRhythm Pharmaceuticals (NASDAQ:RYTM) Given Buy Rating at Needham & Company LLCNeedham & Company LLC reaffirmed a "buy" rating and issued a $50.00 price target on shares of Rhythm Pharmaceuticals in a research note on Friday.April 25, 2024 | marketbeat.comWedge Capital Management L L P NC Sells 28,213 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)Wedge Capital Management L L P NC lessened its stake in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 26.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 76,507 shares of thApril 24, 2024 | globenewswire.comRhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024April 19, 2024 | marketbeat.comFederated Hermes Inc. Reduces Stock Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)Federated Hermes Inc. lowered its position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 1.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,310,955 shares of the company's stock after selling 30,380April 18, 2024 | marketbeat.comRhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Cut to $52.00 by Analysts at Wells Fargo & CompanyWells Fargo & Company reduced their price objective on Rhythm Pharmaceuticals from $53.00 to $52.00 and set an "overweight" rating for the company in a research note on Thursday.April 16, 2024 | globenewswire.comRhythm Pharmaceuticals Announces New Employment Inducement GrantsApril 14, 2024 | finance.yahoo.comMarket Sentiment Around Loss-Making Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)April 11, 2024 | yahoo.comRhythm and Autism comes to Fertile Ground FestivalApril 10, 2024 | markets.businessinsider.com5 Analysts Assess Rhythm Pharmaceuticals: What You Need To KnowApril 10, 2024 | msn.comLee Brice coming to Rhythm City Casino Get Rhythm Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RYTM and its competitors with MarketBeat's FREE daily newsletter. Email Address Bible Shocker: Have You Seen Elon Musk’s Miracle? (Ad)Breaking News: Elon Musk Invents New Type of A.I. (Shocking) Elon Musk is about to shock the world again with this new type of A.I.… Minting new millionaires in the process. Click here for the full story… RYTM Media Mentions By Week RYTM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RYTM News Sentiment▼0.420.42▲Average Medical News Sentiment RYTM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RYTM Articles This Week▼66▲RYTM Articles Average Week Get Rhythm Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RYTM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Dyne Therapeutics News Today ACADIA Pharmaceuticals News Today Janux Therapeutics News Today Indivior News Today PTC Therapeutics News Today MoonLake Immunotherapeutics News Today Bausch Health Companies News Today Merus News Today Maravai LifeSciences News Today Vera Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RYTM) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBill Gates is all about this tiny $2 stockTimothy SykesCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressMan who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.”InvestorPlaceForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the Markets[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rhythm Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
